PF-Atlas › Clinical Trials › NCT04511884

Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid

Next-generation sequencing · Not specified

Registry ID
NCT04511884
Phase
Not specified
Status
Unknown
Drug / intervention
Next-generation sequencing
Sponsor
Shanghai Pulmonary Hospital, Shanghai, China
Start
2020-08-07
Enrollment
100
Locations
2

About this trial

The etiology of cryptogenic organizing pneumonia (COP)was not clear, but previous studies have shown that in some patients, some pathogen could be detected in bronchoalveolar lavage fluid (BALF), and may be one of the causes of COP. This study aimed to screen the pathogenic microorganisms in BALF and lung puncture fluid of the patients with COP through the next-generation sequencing to further clarify the correlation between the incidence of COP and pathogenic microorganisms.

View NCT04511884 on ClinicalTrials.gov →

Explore related

All Next-generation sequencing trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT04511884 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.